Literature DB >> 15956149

Is rate control or rhythm control preferable in patients with atrial fibrillation? An argument for maintenance of sinus rhythm in patients with atrial fibrillation.

Peter Zimetbaum.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15956149     DOI： 10.1161/CIRCULATIONAHA.104.537175

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Controversies in the "pill in the pocket" approach to atrial fibrillation.

Authors:  Alessandro Riccardi; Roberto Lerza
Journal:  Intern Emerg Med       Date:  2008-02-16       Impact factor: 3.397

2.  Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials.

Authors:  Peter Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2006-09       Impact factor: 2.931

3.  Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.

Authors:  Vidal Essebag; Matthew R Reynolds; Tom Hadjis; Robert Lemery; Brian Olshansky; Alfred E Buxton; Mark E Josephson; Peter Zimetbaum
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

4.  Association of Proteinuria and Incident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function.

Authors:  Amber O Molnar; Anan Bader Eddeen; Robin Ducharme; Amit X Garg; Ziv Harel; Megan K McCallum; Jeffrey Perl; Ron Wald; Deborah Zimmerman; Manish M Sood
Journal:  J Am Heart Assoc       Date:  2017-07-06       Impact factor: 5.501

5.  Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR®) Research to Practice (R2P) Project.

Authors:  Jehu S Mathew; Lucas N Marzec; Kevin F Kennedy; Philip G Jones; Paul D Varosy; Frederick A Masoudi; Thomas M Maddox; Larry A Allen
Journal:  J Am Heart Assoc       Date:  2017-08-11       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.